Cargando…
Optimal pharmacological therapy in ST-elevation myocardial infarction—a review: A review of antithrombotic therapies in STEMI
Antithrombotic therapy is an essential component in the optimisation of clinical outcomes in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. There are currently several intravenous anticoagulant drugs available for primary percutaneous...
Autores principales: | Hermanides, R. S., Kilic, S., van ’t Hof, A. W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967999/ https://www.ncbi.nlm.nih.gov/pubmed/29687412 http://dx.doi.org/10.1007/s12471-018-1112-6 |
Ejemplares similares
-
Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
por: Chorell, Elin, et al.
Publicado: (2020) -
Reviewing time intervals from onset of the symptoms to thrombolytic therapy in patients with ST segment elevation myocardial infarction (STEMI)
por: Moeini, Mahin, et al.
Publicado: (2010) -
Management of ST-elevation myocardial infarction in the setting of anterior epistaxis: focused on antiplatelet and antithrombotic therapies
por: Handoyo, Victoria, et al.
Publicado: (2019) -
ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease
por: Livesay, James, et al.
Publicado: (2019) -
Determinants of Exercise Capacity Following ST-Elevation Myocardial Infarction (STEMI)
por: Klimis, Harry, et al.
Publicado: (2021)